These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2608092)

  • 1. Treatment of cutaneous candidosis in guinea pigs: effect of zinc oxide on the antifungal efficacy of nystatin.
    Auger P; Colin P; Joly J; Poirier S; Colin D
    Mycoses; 1989 Sep; 32(9):455-60. PubMed ID: 2608092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis.
    Spraker MK; Gisoldi EM; Siegfried EC; Fling JA; de Espinosa ZD; Quiring JN; Zangrilli SG
    Cutis; 2006 Feb; 77(2):113-20. PubMed ID: 16570675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenomenon of increased resistance of yeast-like fungi to nystatin].
    Nierebińska E; Gwieździński Z; Urbanowski S; Pracz M
    Wiad Lek; 1992 Jun; 45(11-12):427-9. PubMed ID: 1441524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of hamycin, a polyene antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.
    Dhuley JN
    Rocz Akad Med Bialymst; 2000; 45():19-25. PubMed ID: 11712431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy.
    Carter VH; Olansky S
    Arch Dermatol; 1974 Jul; 110(1):81-2. PubMed ID: 4608934
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study.
    Wananukul S; Limpongsanuruk W; Singalavanija S; Wisuthsarewong W
    J Med Assoc Thai; 2006 Oct; 89(10):1654-8. PubMed ID: 17128840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experiences with an antimycotic foam preparation with added prednisolone (Nystacorton foam)].
    Pillwein K; Rauschmeier W; Berger H
    Padiatr Padol; 1986; 21(1):75-80. PubMed ID: 3960566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perianal candidosis--a comparative study with mupirocin and nystatin.
    de Wet PM; Rode H; van Dyk A; Millar AJ
    Int J Dermatol; 1999 Aug; 38(8):618-22. PubMed ID: 10487455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of the antifungal effect of Candistatin paste, a new nystatin preparation, after storage].
    Toyosi JO; Splanemann V
    Mykosen; 1971 Mar; 14(3):145-7. PubMed ID: 5548645
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of novel nystatin nanoemulsion for skin candidosis infections.
    Fernández-Campos F; Clares Naveros B; López Serrano O; Alonso Merino C; Calpena Campmany AC
    Mycoses; 2013 Jan; 56(1):70-81. PubMed ID: 22574899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal topical therapy in oral chronic candidosis. A comparative study.
    Lopez-De-Blanc SA; Salati-De-Mugnolo N; Femopase FL; Benitez MB; Morelatto RA; Astrada-De-Verde L; Masih D
    Med Oral; 2002; 7(4):260-70. PubMed ID: 12134127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans.
    Gallup E; Plott T;
    J Drugs Dermatol; 2005; 4(1):29-34. PubMed ID: 15696982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the efficacy and tolerability of the ''NoAll Bimbi Pasta Trattante'' barrier cream in napkin dermatitis].
    Patrizi A; Neri I; Varotti E; Raone B
    Minerva Pediatr; 2007 Feb; 59(1):23-8. PubMed ID: 17301721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intestinal mycotic involvement: results of 10-day therapy with nystatin].
    Gehse M; Blesch A; Gloor M; Braun KJ
    Mykosen; 1987 Dec; 30(12):609-13. PubMed ID: 3449765
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity and tolerance of a dermatologic preparation with a triamcinolone acetonide and nystatin base in skin diseases caused by Candida albicans].
    Rozzoni M; Pini P; Marchesi L; Cainelli T
    Clin Ter; 1987 Dec; 123(5):363-8. PubMed ID: 2972495
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of pediatric dermatoses with Multilind Heilpaste. Results of a general practice study].
    Schnurr H; Sauter P; Kohler M
    Fortschr Med; 1987 Jun; 105(18):360-2. PubMed ID: 3610005
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo.
    Chami N; Bennis S; Chami F; Aboussekhra A; Remmal A
    Oral Microbiol Immunol; 2005 Apr; 20(2):106-11. PubMed ID: 15720571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical antimicrobial therapy: the efficacy of clioquinol- and tribromphenolbismuth- zinc oxide preparations].
    Kaiser HJ; Kunze J
    Fortschr Med; 1982 Jul; 100(26):1265-7. PubMed ID: 6214486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.